Longitudinal Trends in Costs of Palliative Radiation for Metastatic Prostate Cancer.

ABSTRACT:

Background

In recent years, palliative treatment of prostate cancer metastases has been characterized by the use of more complex radiation treatment, despite a lack of evidence demonstrating a clinical benefit of these technologies in the palliative setting. The impact of adoption of these technologies on the costs of palliative radiation treatment in patients with metastatic prostate cancer remains poorly understood in the general patient population.

Methods

The study was a retrospective analysis of Surveillance, Epidemiology and End Results (SEER) Medicare data of men aged 66 and older who died from metastatic prostate cancer between 2000 and 2007 and received radiation therapy for bony metastases in the last year of life. Direct costs were obtained from Medicare carrier a

SUBMITTER: Robinson TJ 

PROVIDER: S-EPMC4638209 | biostudies-literature | 2015 Nov

REPOSITORIES: biostudies-literature